BCG December 5, 2024
Raakhi Agrawal, Satty Chandrashekhar, Leila Hamidou, Ethan Dabbs, and Ken Keen

The end-to-end journey for a patient starting treatment on branded pharmaceutical products is often complex, time consuming, and unpredictable, leading to high levels of dissatisfaction among health care providers (HCPs), patients, and caregivers alike. Biopharma companies have a unique opportunity to leverage new sources of patient data and technology to create more personalized and seamless patient experiences that have the potential to deliver better health outcomes.

The Push Factors

A number of forces are converging that make now the right time for biopharma companies to take a fresh look at where and how they...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Mark Cuban: A Master Disrupter for American Healthcare
Despite Trump’s Tough Talk On PBMs, GOP House Lets Them Off The Hook
What's next for Amazon in healthcare?
How has U.S. Spending on Health Care Changed Over Time?
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health

Share This Article